Stay updated with breaking news from Human Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Growth outlook is raised by 2 percentage points despite lower expectations for COVID-19 vaccines and therapeutics This increase in growth outlook is driven by more patients getting treated with...
Promising preclinical and early clinical data suggest a role for GLP-1 receptor agonist therapy in treating alcohol use disorder.
Despite a boom of new, cost-efficient options for chronic conditions, prescriber and patient concern over clinical benefit persists.
Russell D Cohen, MD, explains how biosimilars represent an opportunity to expand access and reduce the financial burden of high-cost biologics.
